Rankings
▼
Calendar
MNKD Q4 2016 Earnings — MannKind Corporation Revenue & Financial Results | Market Cap Arena
MNKD
MannKind Corporation
$841M
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$12M
Gross Profit
$621,000
5.0% margin
Operating Income
-$12M
-95.4% margin
Net Income
$54M
435.1% margin
EPS (Diluted)
$0.56
QoQ Revenue Growth
-92.4%
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$107M
Total Liabilities
$291M
Stockholders' Equity
-$184M
Cash & Equivalents
$23M
← FY 2016
All Quarters
Q1 2017 →